Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(7%)
Results Posted
30%(3 trials)

Phase Distribution

Ph phase_3
2
14%
Ph not_applicable
9
64%
Ph phase_2
3
21%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
2(14.3%)
N/ANon-phased studies
9(64.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(10)
Other(2)

Detailed Status

Completed10
unknown2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (21.4%)
Phase 32 (14.3%)
N/A9 (64.3%)

Trials by Status

recruiting17%
enrolling_by_invitation17%
completed1071%
unknown214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14